Literature DB >> 20173083

Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans.

Michael Man1, Mark Farmen, Carmen Dumaual, Choo Hua Teng, Brian Moser, Shin Irie, Gyu Jeong Noh, Reuben Njau, Sandra Close, Stephen Wise, Richard Hockett.   

Abstract

The advent of high-throughput technologies has proven valuable in the assessment of genetic differences and their effects on drug activation, metabolism, disposition, and transport. However, most studies to date have focused on a small number of genes or few alleles, some of which are rare and therefore observed infrequently or lacked rigorous ethnic characterization, thus reducing the ability to extrapolate within and among populations. In this study, the authors comprehensively assessed the allele frequencies of 165 variants comprising 27 drug-metabolizing enzyme and transporter (DMET) genes from 2188 participants across 3 major ethnic populations: Caucasians, Africans, and East Asians. This sample size was sufficiently large to demonstrate genetic differences among these major ethnic groups while concomitantly confirming similarities among East Asian subpopulations (Korean, Han Chinese, and Japanese). A comprehensive presentation of allele and genotype frequencies is included in the online supplement, and 3 of the most widely studied cytochrome P450 (CYP) genes, CYP2D6, CYP2C19, and CYP2C9; 2 non-CYP enzymes, NAT1 and TMPT; and 2 transporter genes, SLCO1B1 and SLCO2B1, are presented herein according to ethnic classification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173083     DOI: 10.1177/0091270009355161

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  66 in total

Review 1.  CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis.

Authors:  Xuan Niu; Ling Mao; Yan Huang; Suraj Baral; Jian-Yong Li; Yuan Gao; Yuan-Peng Xia; Quan-Wei He; Meng-Die Wang; Man Li; Li Zou; Xiao-Ping Miao; Bo Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.

Authors:  In-Suk Kim; Young-Hoon Jeong; Yongwhi Park; Seong-Eun Yoon; Tae Jung Kwon; Jeong Rang Park; Seok-Jae Hwang; Eun-Ha Koh; Choong Hwan Kwak; Jin-Yong Hwang; Sunjoo Kim
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

3.  Effect of genetic and coexisting polymorphisms on platelet response to clopidogrel in Chinese Han patients with acute coronary syndrome.

Authors:  Xu Liu; Yu Luo; Yan Lai; Yian Yao; Jimin Li; Yunkai Wang; S Lilly Zheng; Jianfeng Xu; Xuebo Liu
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

4.  Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.

Authors:  Jung-woo Bae; Chang-ik Choi; Mi-jeong Kim; Da-hee Oh; Seul-ki Keum; Jung-in Park; Bo-hye Kim; Hye-kyoung Bang; Sung-gon Oh; Byung-sung Kang; Hyun-joo Park; Hae-deun Kim; Ji-hey Ha; Hee-jung Shin; Young-hoon Kim; Han-sung Na; Myeon-woo Chung; Choon-gon Jang; Seok-yong Lee
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

5.  Routine genotyping of patients on clopidogrel: Why the resistance?

Authors:  Ganesan Karthikeyan
Journal:  Indian Heart J       Date:  2015-05-13

6.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 7.  Dual antiplatelet therapy in acute ischemic stroke.

Authors:  Negar Asdaghi; Jose G Romano
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

8.  Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.

Authors:  Cheedy Jaja; Latanya Bowman; Leigh Wells; Niren Patel; Hongyan Xu; Matt Lyon; Abdullah Kutlar
Journal:  Clin Transl Sci       Date:  2015-02-02       Impact factor: 4.689

9.  Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention.

Authors:  Xiao-Fang Tang; Jing Wang; Jia-Hui Zhang; Xian-Min Meng; Bo Xu; Shu-Bin Qiao; Yong-Jian Wu; Jue Chen; Yuan Wu; Ji-Lin Chen; Run-Lin Gao; Jin-Qing Yuan; Yue-Jin Yang
Journal:  Eur J Clin Pharmacol       Date:  2012-11-14       Impact factor: 2.953

10.  A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults.

Authors:  Jessica K Roberts; Sarah F Cook; Chris Stockmann; Douglas E Rollins; Diana G Wilkins; Catherine M T Sherwin
Journal:  Clin Drug Investig       Date:  2015-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.